Table 3.
Risk subpathway enrichment analysis of differentially expressed genes (DEGs) in psoriatic patients (P < 0.05)
| ID | Name | Pvalue | DEGs |
|---|---|---|---|
| Path:00140_13 | Steroid hormone biosynthesis | 0.01561 | HSD11B1 |
| Path:00790_4 | Folate biosynthesis | 0.01561 | GGH |
| Path:00240_21 | Pyrimidine metabolism | 0.019471 | CMPK2, RRM2 |
| Path:00240_16 | Pyrimidine metabolism | 0.030339 | CMPK2, RRM2 |
| Path:00531_3 | Glycosaminoglycan degradation | 0.041091 | HYAL4 |
| Path:00240_12 | Pyrimidine metabolism | 0.044307 | CMPK2, RRM2 |
| Path:00140_18 | Steroid hormone biosynthesis | 0.046108 | HSD11B1 |
| Path:00380_10 | Tryptophan metabolism | 0.046108 | KYNU |
| Path:00480_6 | Glutathione metabolism | 0.046108 | RRM2 |